Affiliation:
1. Institute for Clinical Chemistry and Laboratory Medicine University Hospital and Faculty of Medicine, Technische Universität Dresden Dresden Germany
2. Paul Langerhans Institute Dresden, Helmholtz Zentrum München University Hospital and Faculty of Medicine, Technische Universität Dresden Dresden Germany
3. German Center for Diabetes Research Neuherberg Germany
Abstract
AbstractNon‐alcoholic fatty liver disease (NAFLD), recently also defined as metabolic dysfunction‐associated fatty liver disease (MAFLD), is a major health problem, as it affects ∼25% of the population globally and is a major cause of hepatic cirrhosis and thereby liver failure, as well as hepatocellular carcinoma. MALFD comprises a broad range of pathological conditions in the liver, including simple fat accumulation (steatosis) and the more progressive non‐alcoholic steatohepatitis (NASH) that can lead to fibrosis development. Cells of innate immunity, and particularly macrophages, comprising the liver resident Kupffer cells and the recruited monocyte‐derived macrophages, play complex roles in NASH‐related inflammation and disease progression to fibrosis. Here, we discuss the recent developments with regards to the function of liver macrophage subpopulations during MAFLD development and progression.
image
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献